Neopterin in diagnosis and monitoring of infectious diseases

M Eisenhut - Journal of biomarkers, 2013 - Wiley Online Library
Neopterin is produced by activated monocytes, macrophages, and dendritic cells upon
stimulation by interferon gamma produced by T‐lymphocytes. Quantification of neopterin in …

Mass spectrometric identification of urinary biomarkers of pulmonary tuberculosis

F Isa, S Collins, MH Lee, D Decome, N Dorvil… - …, 2018 - thelancet.com
Background Tuberculosis (TB) is the leading infectious cause of death worldwide. A major
barrier to control of the pandemic is a lack of clinical biomarkers with the ability to distinguish …

Non‐invasive biomarkers in exacerbations of obstructive lung disease

G Warwick, PS Thomas, DH Yates - Respirology, 2013 - Wiley Online Library
Background and objective Current methods of diagnosing exacerbations of asthma and
chronic obstructive pulmonary disease (COPD) shed little light on their aetiology or …

Elevated neopterin in tuberculosis and co-infection with HIV and the effect of treatment: A systematic review, meta-analysis, and meta-regression

A Saghazadeh, N Rezaei - International Immunopharmacology, 2022 - Elsevier
Background Neopterin (NEO) is a marker of immune stimulation. Increased NEO levels have
been associated with autoimmune diseases, infections, and malignancies. Studies of NEO …

[HTML][HTML] Clinical importance of serum neopterin level in patients with pulmonary tuberculosis

S Cesur, T Aslan, NT Hoca, F Çimen, G Tarhan… - International journal of …, 2014 - Elsevier
Objective Neopterin is a sensitive marker for cell-mediated immune response. Because of
this, the neopterin levels of body fluids show cell-mediated immune response in different …

[HTML][HTML] Urinary biomarkers of mycobacterial load and treatment response in pulmonary tuberculosis

Q Xia, MH Lee, KF Walsh, K McAulay, JM Bean… - JCI insight, 2020 - ncbi.nlm.nih.gov
BACKGROUND Control of the tuberculosis (TB) pandemic remains hindered in part by a
lack of simple and accurate measures of treatment efficacy, as current gold standard …

[引用][C] Novel tests for diagnosing tuberculous pleural effusion: what works and what does not?

A Trajman, M Pai, K Dheda… - European …, 2008 - Eur Respiratory Soc

Неоптерин-потенциальный диагностический и прогностический маркёр при инфекционных заболеваниях

КР Дудина, ММ Кутателадзе, ОО Знойко… - Казанский …, 2014 - cyberleninka.ru
Освещено клиническое значение определения концентрации неоптерина в
биологических жидкостях. Проанализированы результаты научных исследований …

Сравнительная ценность квантиферонового теста, неоптерина и специфических противотуберкулезных антител для клинико-лабораторной диагностики …

ЕВ Васильева, СВ Лапин, ТВ Блинова… - Клиническая …, 2013 - cyberleninka.ru
Целью работы было сравнение клинико-диагностической ценности лабораторных
методов диагностики туберкулеза (ТБ). Обследованы 63 больных ТБ легких, лица …

Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection

R van Altena, S Duggirala, M IP Groschel… - Current …, 2011 - benthamdirect.com
Humans have always lived with tubercle bacilli. Host susceptibility-both inherited and
acquired-determines whether an individual infected with Mycobacterium tuberculosis will …